OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MRI-based Nomogram Predicts the Risk of Progression of Unresectable Hepatocellular Carcinoma After Combined Lenvatinib and anti-PD-1 Antibody Therapy
Ruofan Sheng, Mengsu Zeng, Kaipu Jin, et al.
Academic Radiology (2021) Vol. 29, Iss. 6, pp. 819-829
Closed Access | Times Cited: 14
Ruofan Sheng, Mengsu Zeng, Kaipu Jin, et al.
Academic Radiology (2021) Vol. 29, Iss. 6, pp. 819-829
Closed Access | Times Cited: 14
Showing 14 citing articles:
Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular carcinoma
Sheng Ye, Qing Wang, Haifeng Liu, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1155, pp. 668-679
Closed Access | Times Cited: 6
Sheng Ye, Qing Wang, Haifeng Liu, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1155, pp. 668-679
Closed Access | Times Cited: 6
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Bin Xu, San-Yuan Dong, Xueli Bai, et al.
Liver Cancer (2022) Vol. 12, Iss. 3, pp. 262-276
Open Access | Times Cited: 23
Bin Xu, San-Yuan Dong, Xueli Bai, et al.
Liver Cancer (2022) Vol. 12, Iss. 3, pp. 262-276
Open Access | Times Cited: 23
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors
Zhen-Xin Zeng, Jiayi Wu, Junyi Wu, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 651-660
Closed Access | Times Cited: 11
Zhen-Xin Zeng, Jiayi Wu, Junyi Wu, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 651-660
Closed Access | Times Cited: 11
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Pretreatment radiomic imaging features combined with immunological indicators to predict targeted combination immunotherapy response in advanced hepatocellular carcinoma
Xu Zhang, Xu Zhang, Qiankun Luo, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Xu Zhang, Xu Zhang, Qiankun Luo, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy
Yi Yang, Lu Li, Ying Xü, et al.
La radiologia medica (2024) Vol. 129, Iss. 2, pp. 188-201
Closed Access | Times Cited: 3
Yi Yang, Lu Li, Ying Xü, et al.
La radiologia medica (2024) Vol. 129, Iss. 2, pp. 188-201
Closed Access | Times Cited: 3
A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features
Ruofan Sheng, Yunfei Zhang, Heqing Wang, et al.
European Radiology (2023) Vol. 34, Iss. 1, pp. 548-559
Closed Access | Times Cited: 7
Ruofan Sheng, Yunfei Zhang, Heqing Wang, et al.
European Radiology (2023) Vol. 34, Iss. 1, pp. 548-559
Closed Access | Times Cited: 7
Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma
Nan-Qing Liao, Zhu‐Jian Deng, Wei Wei, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 247-257
Open Access | Times Cited: 2
Nan-Qing Liao, Zhu‐Jian Deng, Wei Wei, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 247-257
Open Access | Times Cited: 2
Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma
Jie Cheng, X. Li, L. Wang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 6, pp. 2071-2081
Open Access | Times Cited: 5
Jie Cheng, X. Li, L. Wang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 6, pp. 2071-2081
Open Access | Times Cited: 5
Evaluation of immune microenvironment in hepatocellular carcinoma: current advances in CT and MRI imaging techniques
Chenyu Song, Zhou Chun-xiang, Li Lujie, et al.
Chinese Journal of Academic Radiology (2024) Vol. 7, Iss. 1, pp. 8-14
Open Access | Times Cited: 1
Chenyu Song, Zhou Chun-xiang, Li Lujie, et al.
Chinese Journal of Academic Radiology (2024) Vol. 7, Iss. 1, pp. 8-14
Open Access | Times Cited: 1
Multimode Ultrasound Model for Predicting the Early Treatment Response of Anti-VEGF Agents Plus Anti-PD-1 Antibody in Patients with Unresectable Hepatocellular Carcinoma
Zi-Nan Liang, Hong Wang, Wen‐Chao Cui, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 9, pp. 1318-1328
Closed Access | Times Cited: 1
Zi-Nan Liang, Hong Wang, Wen‐Chao Cui, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 9, pp. 1318-1328
Closed Access | Times Cited: 1
Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
Xiaomi Li, Wei Sun, Xiaoyan Ding, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Xiaomi Li, Wei Sun, Xiaoyan Ding, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
A preliminary study of developing an MRI-based model for postoperative recurrence prediction and treatment direction of intrahepatic cholangiocarcinoma
Ruofan Sheng, Beixuan Zheng, Yunfei Zhang, et al.
La radiologia medica (2024)
Closed Access
Ruofan Sheng, Beixuan Zheng, Yunfei Zhang, et al.
La radiologia medica (2024)
Closed Access
What Imaging Modality Is More Effective in Predicting Early Recurrence of Hepatocellular Carcinoma after Hepatectomy Using Radiomics Analysis: CT or MRI or Both?
Qing Wang, Sheng Ye, Zhenxing Jiang, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2012-2012
Open Access | Times Cited: 1
Qing Wang, Sheng Ye, Zhenxing Jiang, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2012-2012
Open Access | Times Cited: 1
